Quince Therapeutics, Inc. (QNCX)
Market Open
15 Jun, 14:14
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 95
+0.02
+1.9385%
$
5.2M Market Cap
- P/E Ratio
- Div Yield
58,167 Volume
0 Eps
$ 0.93
Previous Close Analysts:
Want to track QNCX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Quince Therapeutics, Inc. (QNCX) Statistics
Valuation metrics
Market Cap 5.2M
Enterprise value -12.56M
Trailing P/E (ttm) -0.14
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 0.3
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.23
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 584.45K
Average volume (90 days) 39.06M
Price summary
52-Week low 0.79
52-Week high 45.5
Beta -
50-Day moving average 1.14
200-Day moving average 11.53
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 13 Apr 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.24%
Return on equity 18.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 2.92%
Book value per share (mrq) 3.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
